Auf unserer Website kommen verschiedene Cookies zum Einsatz: Technisch notwendige Cookies verwenden wir zu dem Zweck, Funktionen wie das Login oder einen Warenkorb zu ermöglichen. Optionale Cookies verwenden wir zu Marketing- und Optimierungszwecken, insbesondere um für Sie relevante und interessante Anzeigen bei den Plattformen von Meta (Facebook, Instagram) zu schalten. Optionale Cookies können Sie ablehnen. Mehr Informationen zur Datenerhebung und -verarbeitung finden Sie in unserer Datenschutzerklärung.
Prof. Gil Alcoforado hat sein Leben der wissenschaftlichen Forschung auf dem Gebiet der Parodontologie und der Implantatrehabilitation gewidmet. Seine 35-jährige Karriere wurde durch mehrere Lehrtätigkeiten an einigen der renommiertesten Universitäten im zahnmedizinischen Bereich in Europa und den USA bereichert. Zudem hat er sich intensiv mit sozialem Unternehmertum und freiwilligem Engagement in der Mundpflege beschäftigt, indem er Kampagnen zur Mundhygieneaufklärung für Eltern und Kinder in Ländern durchgeführt hat, in denen Hilfe von größter Bedeutung ist. Im Jahr 1985 wurde Dr. Gil Alcoforado der erste Parodontologe in Portugal. Im selben Jahr trat er der Philip Dear Foundation bei und ist heute der Vorsitzende des International College of Dentists – Europäische Sektion. Er war auch der Gründer und ehemalige Präsident der Portugiesischen Gesellschaft für Parodontologie sowie ehemaliger Präsident der Europäischen Föderation für Parodontologie.
Esthetic Dentistry: Back to the Future25. Apr. 2024 — 27. Apr. 2024Wyndham Grand Levent Hotel, Istanbul, Türkei
Referenten: Gil Alcoforado, Riccardo Ammannato, Oded Bahat, Luiz Narciso Baratieri, Ian Buckle, Zafer Çehreli, Vincent Celenza, Koray Feran, Diego Lops, Magda Mensi, Robert Oretti, Stavros Pelekanos, Jose Manuel Reuss , Finley Sutton
Turkish Academy of Aesthetic Dentistry (EDAD)
12th World Congress of Esthetic Dentistry – IFED 2022
27. Okt. 2022 — 29. Okt. 2022Conrad Abu Dhabi Etihad Towers, Abu Dhabi, Vereinigte Arabische Emirate
Referenten: Gil Alcoforado, Andreas Bindl, Renato Cocconi, Luca Cordaro, David De Franco, Didier Dietschi, Vincent Fehmer, Stefano Gracis, Dan Grauer, Sonia Leziy, Feng Liu, Baldwin Marchack, Francesco Mintrone, Robert Relle, Giovanni Zucchelli
International Federation of Esthetic Dentistry
Zeitschriftenbeiträge dieses Autors
The International Journal of Oral & Maxillofacial Implants, 3/2005
Seiten: 448-454, Sprache: EnglischDavarpanah, Mithridade / Caraman, Mihaela / Szmukler-Moncler, Serge / Jakubowicz-Kohen, Boris / Alcoforado, Gil
Purpose: This article provides preliminary clinical results on the Osseotite NT implant, which was developed to simplify surgical procedure and cover an extended range of indications. Placement characteristics of NT and standard Osseotite implants were also compared in an in vitro study.
Materials and Methods: The in vitro placement characteristics of NT and standard Osseotite implants of 4.0 mm diameter and 8.5 to 15 mm in length were compared. In addition, a total of 182 NT implants (96 maxillary and 86 mandibular) were placed in 92 patients; of these, 87.9% were placed using a 1-stage technique. The implants were placed in healed sites (43.9%), fresh extraction sockets (37.4%), or recent extraction sites (2 months postextraction) (18.7%). Before restoration, healing times of 3 to 4 months in the mandible and 5 to 6 months in the maxilla were allowed. The entered implant length in the osteotomy site before contacting the bony walls (EILOS) was compared, as well as the number of turns and the time required to seat the implants. Cumulative survival rates (CSRs) were calculated for up to 18 months of follow-up after surgery.
Results: The EILOS was between 47.3% and 57.6% of implant length for the NT implants; for the standard implants, it was between 12.0% and 21.2%. With the NT implants, the number of turns and the placement time were reduced by 61% to 64% and 61% to 65%, respectively. In the clinical study, 4 implants failed during the healing period; none failed after prosthesis placement. The CSR was 97.79% for implants placed into fresh or recent extraction sites; in healed sites, the CSR was 98.75%. The cumulative prosthetic success rate was 100%.
Discussion: This new implant design is seated with special drills; the drilling sequence requires less time and less torque than that used for standard implants. The low failure rate after prosthetic loading was consistent with that observed for standard Osseotite implants.
Conclusion: These preliminary data suggest that the NT implant can be predictable in healed sites and fresh or relatively recent extraction sockets.
This multicenter prospective clinical evaluation was undertaken to determine the therapeutic success and marginal bone level stability of 3is self-tapping and ICE implants after 3 years of prosthetic loading. Between July 1995 and June 1996, 189 completely or partially edentulous patients were treated with 614 machined-surface screw-type commercially pure titanium implants (self-tapping or ICE). Two hundred seventy-seven self-tapping implants were placed in 85 patients (average age of 56 years), and 337 ICE implants were placed in 104 patients (average age of 61 years). A total of 360 implants (58.6%) were placed in posterior segments. Easier placement was reported with the ICE implant in normal or dense bone. For the self-tapping implants, survival rates of 92.9% and 91.6% were noted after 1 and 3 years of prosthetic loading, respectively. Survival rates of 95.4% and 93.8% were obtained with the ICE implant for the same periods. Late failures (after loading) were more common than early failures (before loading) for both types of implants. The marginal bone level of 238 self-tapping implants (85.9%) and of 307 ICE implants (91%) was radiographically evaluated at 3 years. Marginal bone level was at the first thread for 95.1% of implants. A loss of marginal bone level of 2 to 4 threads was noted for 4.9% of the evaluated implants. No implant showed bone loss greater than the fourth thread. Overall survival rates of 94.3% and 92.9% were obtained after 1 and 3 years of prosthetic loading, respectively, for 596 and 588 implants.
Schlagwörter: bone density, clinical trials, dental implants, multicenter study, self-tapping dental implants